Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01795248
Recruitment Status : Active, not recruiting
First Posted : February 20, 2013
Last Update Posted : October 3, 2019
Sponsor:
Collaborators:
Novo Nordisk A/S
Rigshospitalet, Denmark
Hvidovre University Hospital
Herlev Hospital
Hillerod Hospital, Denmark
University of Copenhagen
The Novo Nordisk Foundation Center for Basic Metabolic Research
Aarhus University Hospital
Information provided by (Responsible Party):
Tina Vilsboll, University Hospital, Gentofte, Copenhagen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : September 2019
Estimated Study Completion Date : August 2020
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):